Imago Biosciences Inc (IMGO) Peer Comparison
$36.01
$0.00 (0.00%)As on 13-Jan-2023 09:30EDT
Market cap
$1,219 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
7
Div. Yield
0 %
Edit
| Imago Biosciences Inc (IMGO) | AVEO Pharmaceuticals (AVEO) | Oyster Point Pharma (OYST) | Ayala Pharmaceuticals Inc (AYLA) | |
|---|---|---|---|---|
Market cap ($ Mln) |
1,219 | 521 | 300 | 8 |
Revenue ($ Mln) |
-- | 68 | 20 | 2 |
Net Profit ($ Mln) |
-61.64 | -29.04 | -176.65 | -30.42 |
Net Margin (%) |
-8,110.13 | -42.56 | -1,287.59 | -1,755.34 |
RoE (%) |
-33.13 | -88.28 | -- | -184.49 |
Price to Earnings |
-- | -- | -- | -- |
Price-To-Book |
7.04 | 17.96 | 2.39 | 1.02 |
Income Statement ($ Mln)
| Imago Biosciences Inc (IMGO) | AVEO Pharmaceuticals (AVEO) | Oyster Point Pharma (OYST) | Ayala Pharmaceuticals Inc (AYLA) | |
|---|---|---|---|---|
|
Operating Revenue
|
0.00 | 68.17 | 19.58 | 1.73 |
|
Cost of Revenue
|
0.00 | 11.50 | 4.52 | 1.64 |
|
Gross Profit
|
-- | 34.14 | 23.01 | -3.51 |
|
Operating Expenses
|
62.89 | 107.32 | 173.52 | 37.63 |
|
Operating Profit (EBIT)
|
-62.89 | -24.49 | -158.45 | -37.54 |
|
Other Income
|
0.76 | 0.06 | -5.87 | 0.00 |
|
Profit before Tax
|
-61.64 | -29.04 | -176.65 | -37.77 |
|
Provision for Tax
|
0.00 | 0.00 | 0.00 | -0.84 |
|
Profit after Tax (Net Income)
|
-61.64 | -29.04 | -176.65 | -30.42 |
|
Minority Interest
|
0.00 | 0.00 | 0.00 | 0.00 |
|
Consolidated Profit
|
-61.64 | -29.04 | -176.65 | -38.47 |
Liabilities ($ Mln)
| Imago Biosciences Inc (IMGO) | AVEO Pharmaceuticals (AVEO) | Oyster Point Pharma (OYST) | Ayala Pharmaceuticals Inc (AYLA) | |
|---|---|---|---|---|
|
Shareholder's Funds
|
172.62 | 28.85 | -22.20 | 8.16 |
|
Minority Interest
|
0.00 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
0.00 | 29.97 | 102.21 | 0.40 |
|
Current Liabilities
|
13.84 | 42.42 | 29.20 | 5.71 |
|
Total Liabilities
|
224.79 | 105.34 | 222.62 | 1.39 |
Assets ($ Mln)
| Imago Biosciences Inc (IMGO) | AVEO Pharmaceuticals (AVEO) | Oyster Point Pharma (OYST) | Ayala Pharmaceuticals Inc (AYLA) | |
|---|---|---|---|---|
|
Non-Current Assets
|
4.42 | 0.50 | 11.49 | 1.23 |
|
Current Assets
|
182.04 | 100.73 | 97.71 | 13.03 |
|
Total Assets
|
224.79 | 105.34 | 222.62 | 34.66 |
|
Total Debt*
|
0.00 | 38.68 | 94.72 | 0.40 |
|
Net Current Assets
|
168.20 | 69.80 | 68.51 | 7.33 |
Cashflow ($ Mln)
| Imago Biosciences Inc (IMGO) | AVEO Pharmaceuticals (AVEO) | Oyster Point Pharma (OYST) | Ayala Pharmaceuticals Inc (AYLA) | |
|---|---|---|---|---|
|
Cash From Operating Activities
|
-39.76 | -57.26 | -89.37 | -38.36 |
|
Cash Flow from Investing Activities
|
-129.27 | -16.87 | -1.49 | -0.01 |
|
Cash from Financing Activities
|
160.99 | 82.90 | 91.64 | 33.33 |
|
Net Cash Inflow / Outflow
|
-8.04 | 8.78 | 0.79 | -- |
Ratios
Profitability Ratios
| Imago Biosciences Inc (IMGO) | AVEO Pharmaceuticals (AVEO) | Oyster Point Pharma (OYST) | Ayala Pharmaceuticals Inc (AYLA) | |
|---|---|---|---|---|
|
ROCE (%)
|
-58.00 | -111.94 | -53.03 | -110.12 |
|
ROE (%)
|
-33.13 | -88.28 | -70.34 | -184.49 |
|
ROA (%)
|
-27.61 | -22.03 | -101.35 | -85.00 |
|
EBIT Margin (%)
|
-- | -35.93 | -839.04 | -1,803.17 |
|
Net Margin (%)
|
-8,110.13 | -42.56 | -1,287.59 | -1,755.34 |
|
Cash Profit Margin (%)
|
-- | 0.00 | 0.00 | -0.01 |
Growth Ratios
| Imago Biosciences Inc (IMGO) | AVEO Pharmaceuticals (AVEO) | Oyster Point Pharma (OYST) | Ayala Pharmaceuticals Inc (AYLA) | |
|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | 166.96 | 9.15 | -48.48 |
|
EBIT Growth (%)
|
-124.36 | 54.79 | -106.16 | 19.62 |
|
Net Profit Growth (%)
|
-86.02 | 49.58 | -118.55 | 23.19 |
|
EPS Growth (%)
|
89.50 | 58.94 | -113.24 | 34.10 |
|
Book Value Growth (%)
|
-39.97 | -45.31 | -115.67 | -80.66 |
Valuation Ratios
| Imago Biosciences Inc (IMGO) | AVEO Pharmaceuticals (AVEO) | Oyster Point Pharma (OYST) | Ayala Pharmaceuticals Inc (AYLA) | |
|---|---|---|---|---|
|
Price / Earnings
|
-8.97 | -2.90 | -4.75 | -2.96 |
|
Price / Book Value
|
1.77 | 3.37 | 4.80 | 3.49 |
|
Dividend Yield (%)
|
-- | -- | -- | -- |
|
EV/EBITDA
|
-3.86 | -1.18 | -3.90 | -2.01 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- |
Solvency Ratios
| Imago Biosciences Inc (IMGO) | AVEO Pharmaceuticals (AVEO) | Oyster Point Pharma (OYST) | Ayala Pharmaceuticals Inc (AYLA) | |
|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 1.34 | -4.15 | 0.00 |
|
Short term debt to equity ratio
|
0.00 | 0.40 | -0.03 | 0.00 |
|
Current Ratio
|
13.16 | 2.37 | 3.35 | 2.28 |
|
Quick Ratio
|
13.16 | 2.35 | 3.11 | 2.28 |
|
Interest Coverage
|
-127.67 | -1.80 | -13.33 | -217.30 |
Operating Efficiency Ratios
| Imago Biosciences Inc (IMGO) | AVEO Pharmaceuticals (AVEO) | Oyster Point Pharma (OYST) | Ayala Pharmaceuticals Inc (AYLA) | |
|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 28.99 | 67.32 | 7.44 |
|
Asset Turnover
|
0.00 | 0.52 | 0.11 | 0.05 |
|
Receivable days
|
-- | 51.71 | 99.07 | 35.47 |
|
Inventory Days
|
-- | 127.69 | 1,457.65 | -- |
|
Payable days
|
-- | 234.86 | 1,050.84 | 361.50 |
|
Cash Conversion Cycle
|
-- | -55.46 | 505.88 | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
